Navigation Links
Endo Pharmaceuticals Reports Second Quarter Revenues and Updates Financial Guidance, Reflecting the Acquisition of American Medical Systems
Date:8/9/2011

CHADDS FORD, Pa., Aug. 9, 2011 /PRNewswire/ --

  • Total quarterly revenues of $608 million increase 53 percent versus prior year;
  • Reported quarterly diluted EPS of $0.44 versus $0.44 for prior year;
  • Adjusted diluted EPS of $1.05 reflecting growth of 30 percent from 2010;
  • Company increases 2011 revenue guidance to a range of $2.72 to $2.80 billion; and
  • Company increases 2011 adjusted diluted EPS guidance to a range of $4.55 to $4.65 and Reported or GAAP diluted EPS to a range $2.22 to $2.32 reflecting continued strong growth in core operations and the recent acquisition of American Medical Systems.

  • Endo Pharmaceuticals (Nasdaq: ENDP) today reported financial results for the second quarter of 2011.

    Total revenues during the second quarter of 2011 increased 53 percent to $607.6 million, compared with $396.5 million in the same quarter of 2010.  Net income for the three months ended June 30, 2011 was $54.6 million, compared with $51.5 million in the comparable 2010 period.  As detailed in the supplemental financial information below, adjusted net income for the three months ended June 30, 2011, was $128.7 million, compared with $94.7 million in the same period in 2010.  Reported diluted earnings per share for the quarter ended June 30, 2011 were $0.44 compared with $0.44 in the second quarter of 2010. Adjusted diluted earnings per share for the same period were $1.05 compared with $0.81 reported in 2010.($ in thousands, except per share amounts)2nd QuarterSix Months Ended June 3020112010Change20112010ChangeTotal Revenues$607,611

    $396,524

    53%

    $1,167,637

    $760,936

    53%Reported Net Income54,583

    51,460

    6%

    110,370

    111,815

    -1%Reported Diluted EPS0.44

    0.44

    0%

    0.91'/>"/>

    SOURCE Endo Pharmaceuticals
    Copyright©2010 PR Newswire.
    All rights reserved

    Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17

    Related medicine technology :

    1. Auxilium Pharmaceuticals, Inc. Receives Clearance to Resume Clinical Trials for XIAFLEX(TM)
    2. Vion Pharmaceuticals Completes Accrual of 85 Patients to its Pivotal Phase II Trial of Cloretazine(R) (VNP40101M) in Elderly AML
    3. Solvay Pharmaceuticals, Inc. and Wyeth Pharmaceuticals Announce Receipt of an FDA Action Letter for Bifeprunox, an Investigational Treatment for Schizophrenia
    4. Callisto Pharmaceuticals Opens Additional Sites for Phase II Clinical Trial of Atiprimod in Advanced Carcinoid Cancer Patients
    5. WallSt.net (www.wallst.net) Updates the Investment Community Through an All-New Interview With RegeneRx Biopharmaceuticals CEO
    6. Quark Pharmaceuticals, Inc. Presented Positive Preclinical Results of Systemic RNAi Compound for Acute Renal Failure (ARF)
    7. Peregrine Pharmaceuticals Doses First Patient in Cotara(R) Phase II Brain Cancer Trial In India
    8. Nabi Biopharmaceuticals Announces Second Quarter 2007 Financial Results
    9. Access Pharmaceuticals Provides Update on Clinical Development Plan of ProLindac
    10. Quark Pharmaceuticals Extends Research Agreement with State University of New York for Proprietary siRNA Compounds for Acute Hearing Loss
    11. Acura Pharmaceuticals, Inc. Secures Financing to Fund Pivotal Phase III Clinical Trial for Lead Aversion(R) Technology Product Candidate
    Post Your Comments:
    *Name:
    *Comment:
    *Email:
    (Date:12/17/2014)... 2014  Northstar Global Business Services, Inc. (OTCPink:MDIN) ... has made their final decision and has determined ... stock effective December 15, 2014, and has resumed ... and book entry transfer services. All deposit restrictions have ... again fully "DTC Eligible", and has resumed electronic ...
    (Date:12/17/2014)...  IGI Laboratories, Inc. (NYSE MKT: IG; "IGI" or ... of $125 million aggregate principal amount of 3.75% Convertible ... offered and sold only to qualified institutional buyers pursuant ... as amended (the "Securities Act"). The Notes ... year, payable semiannually in arrears on June 15 and ...
    (Date:12/15/2014)... 2014 Research and Markets ( ... "MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular ... their offering. http://photos.prnewswire.com/prnh/20130307/600769 ... applications made a lot of progress in the ... are now accepted in high-reliability environments, and are ...
    Breaking Medicine Technology:Northstar announces that the DTC chill on MDIN has been officially lifted 2Northstar announces that the DTC chill on MDIN has been officially lifted 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 2IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 3IGI Laboratories Announces Closing of $125 Million of 3.75% Convertible Senior Notes Due 2019 4MEMS Gyroscopes Analog Devices ADIS16136 Precision Angular Rate Sensor Reverse Costing Analysis 2
    ... , March 15 /PRNewswire-Asia-FirstCall/ -- Renhuang,Pharmaceuticals, Inc. ... and distributor of botanical products,bio-pharmaceuticals and traditional Chinese medicines ... a conference call at 10:00 a.m. Eastern Time ... financial results for the first quarter,of its fiscal year ...
    ... announced today that it has finalized an amendment to its loan and security agreement with Silicon Valley Bank.  The amendment extends the ... to obtain additional funds if necessary. , ... , ... ...
    Cached Medicine Technology:Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 2Renhuang Schedules Conference Call to Discuss FY 2010 First Quarter Results 3Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 2Otix Global, Inc. Extends Term of Loan and Security Agreement With Silicon Valley Bank 3
    (Date:12/15/2014)... Cancer researchers have just published an important ... deadly malignant pleural mesothelioma. Surviving Mesothelioma has just posted ... Click here to read it now. , Doctors ... and New York’s Langone Medical Center performed complete genetic ... in an effort to pinpoint the genes that are ...
    (Date:12/15/2014)... a leading mobile app development company , custom ... which allows users to keep track of wines they ... right wine. At the center of WineMatch is ... wine information. All this information is assembled to help ... are close counterparts to one another are called Matches. ...
    (Date:12/15/2014)... (HealthDay News) -- Expert pilots process visual information more ... make better decisions during landings, a new study shows. ... for pilots to master, and 36 percent of all ... during final approach and landing. Researchers monitored the ... experienced pilots while they were at the controls of ...
    (Date:12/15/2014)... In support of high-quality independent ... restrictive state laws that may have unintended consequences ... area of public health policy. , The position ... of Independent Review, contends that state legislation that ... review determinations can result in subpar outcomes for ...
    (Date:12/15/2014)... (PRWEB) December 15, 2014 For the second ... Coffee Review “Top 30 Coffees of 2014.” Bird Rock Coffee ... their Guji Zone Ethiopia at number 10. This is the ... , Coffee Review’s selection is ranked on quality, value, and ... Batak scored 96 out of 100, and at $17.99 for ...
    Breaking Medicine News(10 mins):Health News:New Study Reveals Genetic Mutations That May Trigger Mesothelioma, According to Surviving Mesothelioma 2Health News:Use WinMatch Connect App to Keep Track of Wines You Like 2Health News:Study Shows Why Expert Pilots Are Experts 2Health News:NAIRO Calls for Higher Quality Independent Peer Review By Ending Restrictive State Laws 2Health News:Bird Rock Coffee Roasters Ranks Second and Tenth in Coffee Review’s ‘Top 30 Coffees of 2014’ 2
    ... Serena Gordon HealthDay Reporter , TUESDAY, March 8 ... an increased risk of dying, even as long as three ... Those who are discharged from the hospital to a skilled ... according to the study. People between 31 and 65 who ...
    ... -- Treatment for drug addiction is affected by a person,s ... report. A research team at the Brookhaven National Laboratory ... have lower gray matter density -- and therefore fewer neurons ... decision-making, self-control, learning and memory. "This research shows that ...
    ... many hours we spend in light, dreamless slumber. But a ... busy recharging our brain,s learning capacity during this traditionally undervalued ... UC Berkeley researchers have found compelling evidence that ... networking between key regions of the brain to clear a ...
    ... Fla. The Pancreatic Cancer Action Network and the ... Bailey, Ph.D., and E. Scott Seeley, M.D., Ph.D., the ... Leadership Grants. These grants, each totaling $600,000 over five ... Annual Meeting 2011, held April 2-6. "Because of ...
    ... A prolific University of Missouri chemist has discovered ... make certain drugs. Jerry Atwood, Curator,s Professor and ... College of Arts and Science, has recently published a ... that states that highly pressurized carbon dioxide at room ...
    ... VA The National Comprehensive Cancer Network (NCCN), and ... announce a collaboration to advance research for cancer imaging ... qualify imaging sites for upcoming research projects utilizing molecular ... Research Program (ORP), obtains funding to support scientifically meritorious ...
    Cached Medicine News:Health News:Risk of Death May Linger for Trauma Survivors 2Health News:Risk of Death May Linger for Trauma Survivors 3Health News:Genes May Affect Severity of Drug Addiction 2Health News:As we sleep, speedy brain waves boost our ability to learn 2Health News:As we sleep, speedy brain waves boost our ability to learn 3Health News:PanCan-AACR Pathway to Leadership grants awarded 2Health News:PanCan-AACR Pathway to Leadership grants awarded 3Health News:PanCan-AACR Pathway to Leadership grants awarded 4Health News:MU chemist discovers shortcut for processing drugs 2Health News:National Comprehensive Cancer Network and SNM join to advance oncology imaging research 2
    ... offers the comfort of a surgical microscope ... The microscope offers brilliant resolution, large depth ... color reproduction. A separate prism for optimum ... with a special jalousie diaphragm. It offers ...
    The Leica M500 OH3 is an advanced surgical microscope used by neurosurgeons. It is a smart system combining the best optical performance available on the market with an innovative and unique stand....
    Galilean Loupes...
    ... higher magnification for advanced surgical procedures. Prismatic ... at the highest magnification. 3.5x, 4.5x and ... color rendition is ideal for surgical applications. ... produce a superior image. The compact abd ...
    Medicine Products: